2000s

Lars Svensson, MD, PhD, introduces the modified aortic valve reimplantation repair, including the modified elephant trunk procedure. He also opened the Aorta Center and the Marfan and Connective Tissue Disorder Clinic.

A unified campus for Cleveland Clinic Florida opens in Weston, Fla., on Nov. 2, 2001. Among the newest medical centers in the state of Florida, it is also one of the most advanced. Located in southwest Broward County, it is a fully integrated campus where more than 150 physicians practice 35 different medical specialties.

Steven Nissen, MD, spearheads the development of intravascular ultrasound, imaging technology that enables researchers to see and measure the fatty plaque that attaches to the coronary artery walls.

In 2003, Cleveland Clinic Nursing received Magnet status, the highest national award for nursing excellence.

Succeeding Alfred Lerner, Toby Cosgrove, MD, is named CEO and President of Cleveland Clinic. Dr. Cosgrove also serves as Chairman of the Board of Governors from 2004-2017.

A young, Croatian cardiac surgeon visits campus from Brigham and Women's Hospital in Boston. Tomislav Mihaljevic, MD, is eventually recruited by Dr. Cosgrove, whom he succeeds as President and Chief Executive Officer in 2018.

Lars Svensson, MD, PhD, along with E Murat Tuzcu, MD, and Samir Kapadia, MD, pioneer the transcatheter aortic valve replacement (TAVR).

Joseph F Hahn, MD, succeeds Robert Kay, MD, and serves as Chief of Staff from 2005-2014.

In 2005, Tommaso Falcone, MD, completes the first robotic-assisted gynecological surgery—a tubal reversal.

In 2005, Cleveland Clinic bans all smoking on all of its properties. Beginning in 2007, Cleveland Clinic only hired nonsmokers.

A Marc Gillinov, MD, and Toby Cosgrove, MD, develop a clip to isolate the left atrial appendage and prevent strokes associated with atrial fibrillation.

Cleveland Clinic signs an agreement to provide care in Abu Dhabi.

The Office of Patient Experience is launched and the first Chief Experience Officer is appointed in 2007.

CEO and President Toby Cosgrove, MD, reorganizes Cleveland Clinic's medical and surgical departments and support services into 27 patient-centered institutes centered on specific diseases and body systems.

In 2007, Steven Nissen, MD, discovers that a popular diabetes drug, rosiglitazone (Avandia) raises risk of heart attack and death. This is one of three drugs that Dr. Nissen got banned by the FDA; the others were rofecoxib (Vioxx) and muragitazar.

Gösta Pettersson, MD, PhD, pioneers bronchial artery revascularization to better restore blood supply to the bronchial arteries, reducing complications in patients undergoing lung transplant.

In early 2007, Cleveland Clinic Canada opens in downtown Toronto.

Bruce Trapp, PhD, discovers growth of new neurons in adult brains.

Maria Siemionow, MD, PhD, leads the team that performs America's first face transplant.

The Miller Family Pavilion and Glickman Tower opens, dramatically transforming the look and ambience of main campus. The building added 1 million square feet and 100 new beds, and was designed with an unprecedented level of attention paid to patient and visitor comfort.

Charis Eng, MD, PhD, discovers two genes linked to cancer. Dr. Eng received the American Cancer Society’s Medal of Honor, the organization’s highest award, for this work in 2018.

In June 2009, President Barack Obama visits Cleveland Clinic to, in his own words, "see how Cleveland Clinic delivers the best possible care at the lowest possible cost." Six months later, Cleveland Clinic received a prominent national call-out with the publication of a Newsweek story entitled, "The Hospital That Could Cure Healthcare."